FOXA 1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome-Reference-Cited by-同舟云学术

FOXA 1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome

Published:2018-10-12 Issue:11 Volume:12 Page:1884-1894
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Schrijver Willemijne¹,Schuurman Karianne²,Rossum Annelot³,Droog Marjolein²,Jeronimo Carmen⁴,Salta Sofia⁴,Henrique Rui⁵,Wesseling Jelle⁶,Moelans Cathy¹,Linn Sabine C.¹³⁷,Heuvel Michel⁸,Diest Paul¹,Zwart Wilbert²⁹

Affiliation:

1. Department of Pathology University Medical Center Utrecht The Netherlands

2. Division of Oncogenomics Oncode Institute The Netherlands Cancer Institute Amsterdam The Netherlands

3. Division of Molecular Pathology The Netherlands Cancer Institute Amsterdam The Netherlands

4. Cancer Biology and Epigenetics Group Research Center (CI‐IPOP) Portuguese Oncology Institute of Porto Portugal

5. Department of Pathology Portuguese Oncology Institute of Porto (IPO Porto) Portugal

6. Division of Pathology The Netherlands Cancer Institute Amsterdam The Netherlands

7. Division of Medical Oncology The Netherlands Cancer Institute Amsterdam The Netherlands

8. Division of Thoracic Oncology The Netherlands Cancer Institute Amsterdam The Netherlands

9. Laboratory of Chemical Biology and Institute for Complex Molecular Systems Department of Biomedical Engineering Eindhoven University of Technology The Netherlands

Funder

Stichting A Sister's Hope

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

KWF Kankerbestrijding

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12353

Reference32 articles.

1. Management of malignant pleural effusions;American Thoracic Society;Am J Respir Crit Care Med,2000